Vascular stenosis: biology and interventions
- PMID: 18089964
- DOI: 10.1097/MNH.0b013e3282efa57f
Vascular stenosis: biology and interventions
Abstract
Purpose of review: The aim of this review will be to summarize recent concepts pertaining to the pathophysiology of dialysis access stenosis and to then use this information to highlight novel interventions (both diagnostic and therapeutic) for dialysis access dysfunction. The studies covered in this review will include experimental and observational studies in addition to clinical trials.
Recent findings: An important biological focus of this review will be an emphasis on the role of the adventitia and progenitor cells in the pathogenesis of dialysis access dysfunction. The main interventional focus will be on access surveillance, local drug delivery and other novel therapeutic interventions. An important underlying theme throughout this review will be an emphasis on arteriovenous fistulae and on the many advantages of local therapeutic interventions in the specific clinical setting of dialysis access dysfunction.
Summary: Vascular access dysfunction remains a significant cause of morbidity and mortality for hemodialysis patients. We believe that a better understanding of the biological mechanisms of vascular access stenosis will help guide the development of novel therapies to prevent and treat dialysis access stenosis.
Similar articles
-
Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint.J Am Soc Nephrol. 2006 Apr;17(4):1112-27. doi: 10.1681/ASN.2005050615. J Am Soc Nephrol. 2006. PMID: 16565259 Review.
-
Vascular access in hemodialysis: issues, management, and emerging concepts.Cardiol Clin. 2005 Aug;23(3):249-73. doi: 10.1016/j.ccl.2005.04.004. Cardiol Clin. 2005. PMID: 16084276 Review.
-
Understanding the pathophysiology of hemodialysis access problems as a prelude to developing innovative therapies.Nat Clin Pract Nephrol. 2008 Nov;4(11):628-38. doi: 10.1038/ncpneph0947. Epub 2008 Sep 23. Nat Clin Pract Nephrol. 2008. PMID: 18813234 Review.
-
Hemodialysis vascular access dysfunction: from pathophysiology to novel therapies.Blood Purif. 2003;21(1):99-110. doi: 10.1159/000067863. Blood Purif. 2003. PMID: 12596755 Review.
-
Central vein stenosis: a nephrologist's perspective.Semin Dial. 2007 Jan-Feb;20(1):53-62. doi: 10.1111/j.1525-139X.2007.00242.x. Semin Dial. 2007. PMID: 17244123 Review.
Cited by
-
MMP-9 Deletion Attenuates Arteriovenous Fistula Neointima through Reduced Perioperative Vascular Inflammation.Int J Mol Sci. 2021 May 21;22(11):5448. doi: 10.3390/ijms22115448. Int J Mol Sci. 2021. PMID: 34064140 Free PMC article.
-
Characterization of a model of an arteriovenous fistula in the rat: the effect of L-NAME.Am J Pathol. 2010 May;176(5):2530-41. doi: 10.2353/ajpath.2010.090649. Epub 2010 Apr 2. Am J Pathol. 2010. PMID: 20363917 Free PMC article.
-
Role of the VEGF 936 gene polymorphism and VEGF-A levels in the late-term arteriovenous fistula thrombosis in patients undergoing hemodialysis.Int Urol Nephrol. 2014 Sep;46(9):1815-23. doi: 10.1007/s11255-014-0711-4. Epub 2014 Apr 20. Int Urol Nephrol. 2014. PMID: 24748065
-
Improved cumulative survival in fistulas requiring surgical interventions to promote fistula maturation compared with endovascular interventions.Semin Dial. 2013 Jan-Feb;26(1):85-9. doi: 10.1111/j.1525-139X.2012.01060.x. Epub 2012 Mar 9. Semin Dial. 2013. PMID: 22404567 Free PMC article.
-
Functioning of an arteriovenous fistula requires heme oxygenase-2.Am J Physiol Renal Physiol. 2013 Aug 15;305(4):F545-52. doi: 10.1152/ajprenal.00234.2013. Epub 2013 May 15. Am J Physiol Renal Physiol. 2013. PMID: 23678042 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials